Lelio De Souza Junior Sells 41,541 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYAGet Free Report) VP Lelio De Souza Junior sold 41,541 shares of the business’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $15.00, for a total transaction of $623,115.00. Following the completion of the sale, the vice president owned 36,204 shares in the company, valued at approximately $543,060. This trade represents a 53.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Lelio De Souza Junior also recently made the following trade(s):

  • On Thursday, April 9th, Lelio De Souza Junior sold 16,279 shares of Afya stock. The shares were sold at an average price of $14.53, for a total transaction of $236,533.87.
  • On Tuesday, April 7th, Lelio De Souza Junior sold 26,753 shares of Afya stock. The shares were sold at an average price of $14.95, for a total transaction of $399,957.35.

Afya Stock Performance

NASDAQ:AFYA opened at $15.00 on Thursday. The company has a 50-day moving average of $14.30 and a 200-day moving average of $14.53. The firm has a market cap of $1.41 billion, a price-to-earnings ratio of 9.80, a price-to-earnings-growth ratio of 1.52 and a beta of 0.32. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya Limited has a twelve month low of $13.00 and a twelve month high of $18.01.

Analysts Set New Price Targets

Several research analysts have issued reports on AFYA shares. Wall Street Zen lowered shares of Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd. Bank of America reaffirmed a “neutral” rating on shares of Afya in a research report on Thursday, June 11th. JPMorgan Chase & Co. decreased their target price on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a report on Monday, June 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Monday, April 20th. Finally, Zacks Research downgraded shares of Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. One research analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.10.

View Our Latest Stock Report on Afya

Hedge Funds Weigh In On Afya

Institutional investors and hedge funds have recently bought and sold shares of the business. Van ECK Associates Corp lifted its position in shares of Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after purchasing an additional 1,377 shares in the last quarter. Daiwa Securities Group Inc. acquired a new stake in shares of Afya during the 4th quarter valued at $43,000. Arrowstreet Capital Limited Partnership grew its holdings in shares of Afya by 5.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after acquiring an additional 3,626 shares in the last quarter. Militia Capital Partners LP acquired a new position in shares of Afya in the second quarter worth $71,000. Finally, Fairtree Asset Management Pty Ltd raised its holdings in shares of Afya by 22.3% during the fourth quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company’s stock worth $473,000 after acquiring an additional 5,599 shares in the last quarter. Hedge funds and other institutional investors own 88.02% of the company’s stock.

About Afya

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

Recommended Stories

Insider Buying and Selling by Quarter for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.